Melatonin receptors: Role on sleep and circadian rhythm regulation

Dubocovich, 2003, Molecular pharmacology, regulation and function of mammalian melatonin receptors, Front Biosci, 8, d1093, 10.2741/1089

Dubocovich, 2005, Functional MT1 and MT2 melatonin receptors in mammals, Endocrine, 27, 101, 10.1385/ENDO:27:2:101

Reiter, 1991, Melatonin: the chemical expression of darkness, Mol Cell Endocrinol, 79, C153, 10.1016/0303-7207(91)90087-9

Reiter, 1993, The melatonin rhythm: both a clock and a calendar, Experientia, 49, 654, 10.1007/BF01923947

Borjigin, 1999, The pineal gland and melatonin: molecular and pharmacologic regulation, Annu Rev Pharmacol Toxicol, 39, 53, 10.1146/annurev.pharmtox.39.1.53

Reppert, 1996, Melatonin receptors step into the light: cloning and classification of subtypes, Trends Pharmacol Sci, 17, 100, 10.1016/0165-6147(96)10005-5

Dubocovich, 1997, Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor, Naunyn Schmiedebergs Arch Pharmacol, 355, 365, 10.1007/PL00004956

von Gall, 2000, Melatonin limits transcriptional impact of phosphoCREB in the mouse SCN via the Mel1a receptor, Neuroreport, 11, 1803, 10.1097/00001756-200006260-00002

Jin, 2003, Targeted disruption of the mouse Mel(1b) melatonin receptor, Mol Cell Biol, 23, 1054, 10.1128/MCB.23.3.1054-1060.2003

Hunt, 2001, Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock, Am J Physiol Cell Physiol, 280, C110, 10.1152/ajpcell.2001.280.1.C110

Kilduff, 1998, Circadian regulation of sleep, 135

Kunz, 2004, Melatonin in patients with reduced REM sleep duration: two randomized controlled trials, J Clin Endocrinol Metab, 89, 128, 10.1210/jc.2002-021057

Dubocovich, 2005, Effect of MT melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL/6 mouse, J Pineal Res, 39, 113, 10.1111/j.1600-079X.2005.00230.x

Liu, 1997, Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock, Neuron, 19, 91, 10.1016/S0896-6273(00)80350-5

Shibata, 1989, Effects of melatonin on neuronal activity in the rat suprachiasmatic nucleus in vitro, Neurosci Lett, 97, 140, 10.1016/0304-3940(89)90153-5

McArthur, 1997, Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dusk and dawn, Endocrinology, 138, 627, 10.1210/endo.138.2.4925

Zhdanova, 2005, Melatonin as a hypnotic: pro, Sleep Med Rev, 9, 51, 10.1016/j.smrv.2004.04.003

Zhdanova, 2002, Melatonin promotes sleep in three species of diurnal nonhuman primates, Physiol Behav, 75, 523, 10.1016/S0031-9384(02)00654-6

Arendt, 2005, Melatonin as a chronobiotic, Sleep Med Rev, 9, 25, 10.1016/j.smrv.2004.05.002

Boutin, 2005, Molecular tools to study melatonin pathways and actions, Trends Pharmacol Sci, 26, 412, 10.1016/j.tips.2005.06.006

Dubocovich, 1998, Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms, FASEB J, 12, 1211, 10.1096/fasebj.12.12.1211

Ginter P, Zelivyanskaya ML, Dubocovich ML. Melatonin receptor mRNA expression in C3H/HEN mouse brain 35th Society for Neuroscience Annual Meeting Program No. 766.22, Abstract Viewer/Itinerary Planner. November 12–16, Washington, DC, 2005.

Kenakin, 2000, Efficacy: molecular mechanisms and operational methods of measurement. A new algorithm for the prediction of side effects, 183

Urban, 2007, Functional selectivity and classical concepts of quantitative pharmacology, J Pharmacol Exp Ther, 320, 1, 10.1124/jpet.106.104463

Kato, 2005, Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, Neuropharmacology, 48, 301, 10.1016/j.neuropharm.2004.09.007

Audinot, 2003, New selective ligands of human cloned melatonin MT1 and MT2 receptors, Naunyn Schmiedebergs Arch Pharmacol, 367, 553, 10.1007/s00210-003-0751-2

Mulchahey, 2004, A single blind, placebo controlled, across groups dose escalation study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the melatonin analog beta-methyl-6-chloromelatonin, Life Sci, 75, 1843, 10.1016/j.lfs.2004.03.023

Dubocovich, 2006, Agomelatine targets a range of major depressive disorder symptoms, Curr Opin Investig Drugs, 7, 670

Browning, 2000, Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors, Br J Pharmacol, 129, 877, 10.1038/sj.bjp.0703130

Soares, 2003, Functional melatonin receptors in rat ovaries at various stages of the estrous cycle, J Pharmacol Exp Ther, 306, 694, 10.1124/jpet.103.049916

Dubocovich, 1998, The efficacy of melatonin receptor analogues is dependent on the level of human melatonin receptor subtype expression, 289

Sugden, 1999, Design of subtype selective melatonin receptor agonists and antagonists, Reprod Nutr Dev, 39, 335, 10.1051/rnd:19990306

Descamps-Franðcois, 2003, Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands, J Med Chem, 46, 1127, 10.1021/jm0255872

Lewy, 1998, The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light, Chronobiol Int, 15, 71, 10.3109/07420529808998671

Dubocovich, 2007, Melatonin receptors in central nervous system, 37

Hudson, 2005, Distinct roles for MT1 and MT2 melatonin (MLT) receptors in MLT-mediated phase shifts of circadian rhythms, Neuropsychopharmacology, 30, S267

Hudson, 2004, Melatonin (MLT) phase advances the circadian rhythm of neuronal firing rate in suprachiasmatic nucleus (SCN) slices of C57BL/6 mice through activation of MT2 MLT receptors, FASEB J, 18

Ferguson, 1998, G protein-coupled receptor adaptation mechanisms, Semin Cell Dev Biol, 9, 119, 10.1006/scdb.1997.0216

Gerdin, 2004, Melatonin-mediated regulation of human MT(1) melatonin receptors expressed in mammalian cells, Biochem Pharmacol, 67, 2023, 10.1016/j.bcp.2004.01.027

Gerdin, 2004, Melatonin desensitizes endogenous MT2 melatonin receptors in the rat suprachiasmatic nucleus: relevance for defining the periods of sensitivity of the mammalian circadian clock to melatonin, FASEB J, 18, 1646, 10.1096/fj.03-1339com

Dollins, 1994, Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance, Proc Natl Acad Sci USA, 91, 1824, 10.1073/pnas.91.5.1824